Versus the effects of metformin and rosiglitazone on clinical symptoms and serum hormonal levels in overweight patients with polycystic ovary syndrome

R., Al Jamal; W., Hammoud; M., Tabbaa

R., Al Jamal; W., Hammoud; M., Tabbaa.

Arab Journal of Pharmaceutical Sciences. 2010; 4 (2): 57-64

in Ar | IMEMR | ID: emr-98779

Responsible library: EMRO

Subject(s)

Humans; Female; Thiazolidinediones; Polycystic Ovary Syndrome/therapy; Overweight; Hirsutism; Treatment Outcome; Hormones/blood; Body Mass Index

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Polycystic Ovary Syndrome / Body Mass Index / Treatment Outcome / Thiazolidinediones / Overweight / Hirsutism / Hormones Limits: Female / Humans Language: Ar Journal: Arab J. Pharm. Sci. Year: 2010

Search on Google

Add to My VHL

XML